About

Leonard Chu, PhD, Deputy Director at Altek Biotechnology, holds a doctoral degree from the Georgia Institute of Technology (GA, US), focusing on developing dissolving microneedles. He has a variety of industry experience, serving in both technical and project management roles. Dr Chu has led customer projects from the design phase to the validation phase, involving fully automated assembly.

Currently he leads the Drug Delivery Business Unit to develop a portfolio of smart injection devices, including autoinjectors, pen injectors, precision dosing on-body injectors and large-volume wearable injectors.

Contributions

INJECTION

VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM

Leonard Chu discusses three trends in self-administration that are aligned with emerging smart devices – device versatility, sustainability and digitalisation – and the benefits offered by the Alcee injection platform.

More contributions

WEARABLES

ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM

Leonard Chu presents the Altek Biotechnology's Alby injection platform and highlights its versatility as a delivery platform for large-volume subcutaneous injections.